Picture of Aethlon Medical logo

AEMD Aethlon Medical Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for Aethlon Medical, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

2021
March 31st
2022
March 31st
2023
March 31st
2024
March 31st
2025
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-7.89-10.4-12-12.2-13.4
Depreciation
Non-Cash Items0.7770.7811.221.245.31
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.31-0.2510.0650.4790.094
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-6.76-9.77-10.5-10.1-7.65
Capital Expenditures-0.06-0.349-0.943-0.2510
Purchase of Fixed Assets
Cash from Investing Activities-0.06-0.349-0.943-0.2510
Financing Cash Flow Items-0.165
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities7.1317.48.911.297.73
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.3047.25-2.54-9.090.07